or Try an Advanced Search...

    Cognitive Dysfunction Stocks List

    Symbol Grade Name % Change
    ITCI A Intra-Cellular Therapies Inc. 2.11
    PRTC D PureTech Health plc 2.36
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Alzheimer's Disease Biopharmaceutical Dementia Dysfunction Parkinson's Disease Psychiatry Schizophrenia Aging Associated Diseases Autism Autism Spectrum Disorder Biology Biomarker Technology Biomarkers Biotechnology Bipolar Disorder Cardiovascular And Other Diseases Central Nervous System Disorders Choline Chronic Disease Cognitive Disorders

    Related ETFs - A few ETFs which own one or more of the above listed Cognitive Dysfunction stocks.

    Symbol Grade Name Weight
    PSIL B AdvisorShares Psychedelics ETF 3.89
    IBRN B iShares Neuroscience and Healthcare ETF 3.71
    XPH B SPDR S&P Pharmaceuticals ETF 3.49
    FBT A First Trust Amex Biotech Index Fund 3.41
    IHE D iShares U.S. Pharmaceutical ETF 2.93
    View all Cognitive Dysfunction ETFs...
    Compare ETFs
    Compare IBRN to IHE Compare PSIL to IHE Compare XPH to FBT

        Cognitive Dysfunction Stocks Recent News

        Date Stock Title
        Nov 1 ITCI Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Oct 31 ITCI Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...
        Oct 30 ITCI Intra-Cellular Therapies, Inc. (ITCI) Q3 2024 Earnings Call Transcript
        Oct 30 ITCI Intra-Cellular jumps on Q3 beat as Caplyta outlook brightens
        Oct 30 ITCI ITCI Q3 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales
        Oct 30 ITCI Intra-Cellular Therapies (ITCI) Reports Q3 Loss, Tops Revenue Estimates
        Oct 30 ITCI Intra-Cellular: Q3 Earnings Snapshot
        Oct 30 ITCI Intra-Cellular Therapies GAAP EPS of -$0.25 misses by $0.04, revenue of $175.4M beats by $3.05M
        Oct 30 ITCI Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
        Oct 30 PRTC PureTech to Present at Two Upcoming Investor Conferences
        Oct 29 ITCI Intra-Cellular Therapies Q3 2024 Earnings Preview
        Related Industries: Biotechnology
        Related Stock Lists: Alzheimer's Disease Biopharmaceutical Dementia Dysfunction Parkinson's Disease Psychiatry Schizophrenia Aging Associated Diseases Autism Autism Spectrum Disorder Biology Biomarker Technology Biomarkers Biotechnology Bipolar Disorder Cardiovascular And Other Diseases Central Nervous System Disorders Choline Chronic Disease Cognitive Disorders
        Cognitive Dysfunction

        Cognitive Dysfunction is a term used to describe a decline in mental abilities such as memory, language, problem-solving, and decision-making. It can be caused by a variety of factors, including aging, stroke, dementia, and traumatic brain injury. Symptoms of cognitive dysfunction can include difficulty concentrating, confusion, difficulty with language, and difficulty with problem-solving.

        Browse All Tags